2002
DOI: 10.1128/mcb.22.13.4929-4942.2002
|View full text |Cite
|
Sign up to set email alerts
|

The Bax Subfamily of Bcl2-Related Proteins Is Essential for Apoptotic Signal Transduction by c-Jun NH2-Terminal Kinase

Abstract: Targeted gene disruption studies have established that the c-Jun NH2-terminal kinase (JNK) signaling pathway is required for stress-induced release of mitochondrial cytochrome c and apoptosis. Here we demonstrate that activated JNK is sufficient to induce rapid cytochrome c release and apoptosis. However, activated JNK fails to cause death in cells deficient of members of the Bax subfamily of proapoptotic Bcl2-related proteins. Furthermore, exposure to stress fails to activate Bax, cause cytochrome c release, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

17
373
0
1

Year Published

2002
2002
2015
2015

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 454 publications
(391 citation statements)
references
References 72 publications
(127 reference statements)
17
373
0
1
Order By: Relevance
“…Our findings are in accord to those of Liu et al, 2001, reporting that sensitisation of MM cells toward TRAIL by chemotherapeutic is dependent on the mitochondrial pathway, in a c-Jun N-terminal kinase (JNK)-dependent manner (Vivo et al, 2003). Thus, a-TOS, although also acting via the JNK pathway (Yu et al, 2001) signalling downstream through Bax (Lei et al, 2002), promotes the receptor-dependent pathway, thereby maximizing the apoptotic potential of the cell. In conclusion, our data show that a-TOS efficiently potentiates TRAIL killing of MM cells that are highly resistant to established treatment via mitochondrial mechanisms, and prompt testing of TRAIL and a-TOS, as well as other vitamin E analogues (Birringer et al, 2003), in preclinical models of MM.…”
supporting
confidence: 89%
“…Our findings are in accord to those of Liu et al, 2001, reporting that sensitisation of MM cells toward TRAIL by chemotherapeutic is dependent on the mitochondrial pathway, in a c-Jun N-terminal kinase (JNK)-dependent manner (Vivo et al, 2003). Thus, a-TOS, although also acting via the JNK pathway (Yu et al, 2001) signalling downstream through Bax (Lei et al, 2002), promotes the receptor-dependent pathway, thereby maximizing the apoptotic potential of the cell. In conclusion, our data show that a-TOS efficiently potentiates TRAIL killing of MM cells that are highly resistant to established treatment via mitochondrial mechanisms, and prompt testing of TRAIL and a-TOS, as well as other vitamin E analogues (Birringer et al, 2003), in preclinical models of MM.…”
supporting
confidence: 89%
“…25 In a number of different cellular models, inhibition of both JNK and p38 prevented the translocation of Bax. [25][26][27] For peroxynitrite-induced apoptosis to occur, MLK, p38 and JNK had to be simultaneously activated, inducing Bax translocation to the mitochondria.…”
Section: Discussionmentioning
confidence: 99%
“…38 JNK in response to cellular stress, such as ROS and UV light, has been reported to act as a proapoptotic signal transducer to induce mitochondrial apoptosis. [39][40][41] p38 is up-regulated by a variety of bacterial pathogens, proinflammatory cytokines, growth factors and environmental stress, which plays an important role in inflammatory, immune response, cell growth inhibition and apoptosis. The effect of SK228 on these signaling transducers is worthy of further investigation.…”
Section: Discussionmentioning
confidence: 99%